Literature DB >> 28724306

New psychological therapies for irritable bowel syndrome: mindfulness, acceptance and commitment therapy (ACT).

Beatriz Sebastián Sánchez1, Jesús Gil Roales-Nieto1, Nuno Bravo Ferreira2, Bárbara Gil Luciano1, Juan José Sebastián Domingo3.   

Abstract

The current goal of treatment in irritable bowel syndrome (IBS) focuses primarily on symptom management and attempts to improve quality of life. Several treatments are at the disposal of physicians; lifestyle and dietary management, pharmacological treatments and psychological interventions are the most used and recommended. Psychological treatments have been proposed as viable alternatives or compliments to existing care models. Most forms of psychological therapies studied have been shown to be helpful in reducing symptoms and in improving the psychological component of anxiety/depression and health-related quality of life. According to current NICE/NHS guidelines, physicians should consider referral for psychological treatment in patients who do not respond to pharmacotherapy for a period of 12 months and develop a continuing symptom profile (described as refractory irritable bowel syndrome). Cognitive behavioral therapy (CBT) is the best studied treatment and seems to be the most promising therapeutic approach. However, some studies have challenged the effectiveness of this therapy for irritable bowel syndrome. One study concluded that cognitive behavioral therapy is no more effective than placebo attention control condition and another study showed that the beneficial effects wane after six months of follow-up. A review of mind/body approaches to irritable bowel syndrome has therefore suggested that alternate strategies targeting mechanisms other than thought content change might be helpful, specifically mindfulness and acceptance-based approaches. In this article we review these new psychological treatment approaches in an attempt to raise awareness of alternative treatments to gastroenterologists that treat this clinical syndrome.

Entities:  

Mesh:

Year:  2017        PMID: 28724306     DOI: 10.17235/reed.2017.4660/2016

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  5 in total

1.  The Emerging Role of Brain-Gut Therapies for Irritable Bowel Syndrome.

Authors:  Megan E Riehl
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

2.  Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial.

Authors:  Javad Mohamadi; Firoozeh Ghazanfari; Fazlollah Mir Drikvand
Journal:  Psychiatr Q       Date:  2019-09

3.  A Two-Day Acceptance and Commitment Therapy (ACT) Workshop Increases Presence and Work Functioning in Healthcare Workers.

Authors:  Rainer Gaupp; Marc Walter; Klaus Bader; Charles Benoy; Undine E Lang
Journal:  Front Psychiatry       Date:  2020-10-05       Impact factor: 4.157

4.  Preliminary investigation of the associations between psychological flexibility, symptoms and daily functioning in people with chronic abdominal pain.

Authors:  Lin Yu; Yoram Inspector; Lance M McCracken
Journal:  Br J Pain       Date:  2020-06-03

5.  The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.

Authors:  Nuno Ferreira; Antonina Mikocka-Walus; Miranda A L van Tilburg; Lesley A Graff; Pragalathan Apputhurai; Manuel Barreiro-de Acosta; Floor Bennebroek Evertsz; Johan Burisch; Bobby Lo; Megan Petrik; Inês A Trindade; Sharon Jedel; Gabriele Moser; Anna Mokrowiecka; Charles N Bernstein; Dan Dumitrascu; Alexander C Ford; Andreas Stengel; Richard Gearry; Simon R Knowles
Journal:  J Psychosom Res       Date:  2021-06-29       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.